SLAM
CGON icon

Swiss Life Asset Management’s CG Oncology CGON Stock Holding History

Swiss Life Asset Management’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$208K Buy
+2,921
New +$191K ﹤0.01% 1509

Other funds holding CGON

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Swiss Life Asset Management's CGON Position: Q2 2026 in Review

Swiss Life Asset Management opened a new position in CG Oncology (CGON) in Q2 2026: 2,921 shares worth $208K. The stake represents ﹤0.01% of the portfolio and ranks #1509 among its holdings.

113 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • Swiss Life Asset Management held 2,921 shares of CG Oncology worth $208K as of Q2 2026.
  • CG Oncology was a new Swiss Life Asset Management position in Q2 2026.
  • CG Oncology made up ﹤0.01% of Swiss Life Asset Management's portfolio in Q2 2026, its #1509 holding.
  • 113 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on Swiss Life Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.